Your session is about to expire
← Back to Search
Stromal Vascular Fraction
Adipose-derived SVF for Treatment of Erectile Dysfunction (ED)
N/A
Waitlist Available
Research Sponsored by GID BIO, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
This trial will test if a single injection of cells taken from a man's own fat tissue can safely and effectively treat erectile dysfunction. It aims to help men who do not respond well to standard treatments by improving blood flow and repairing tissue. The cells have been investigated for their potential to treat erectile dysfunction by creating a pro-repair environment at the site of injury.
Eligible Conditions
- Erectile Dysfunction
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adverse Events
Secondary study objectives
International Index of Erectile Function (IIEF)
Other study objectives
Partner Satisfaction Questionnaire
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Each subject will receive a single injection of autologous adipose-derived stromal vascular fraction (SVF) and will be monitored for 6 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GID SVF-2
2016
N/A
~50
Find a Location
Who is running the clinical trial?
GID BIO, Inc.Lead Sponsor
4 Previous Clinical Trials
180 Total Patients Enrolled